Hansol Chemical discloses 2026 Corporate Governance Report... Strengthened shareholder returns via dividend hike and share cancellation, but some governance non-compliances remain to be addressed


  • Hansol Chemical disclosed its 2026 Corporate Governance Report as of May 28, 2026, transparently presenting compliance status of 15 key indicators including board composition, shareholder rights protection, and audit body operation. Compliance rate remains similar to prior year, but some non-compliances persist such as no electronic voting, lack of CEO succession policy, and absence of independent internal audit support organization, requiring investor attention.
  • Strengthened shareholder return: Annual dividend per share increased from KRW 2,100 to KRW 2,600 (20.4% of separate net income). Additionally, a KRW 60 billion share buyback plan and a share cancellation decision were made, contributing to stock price stability and shareholder value enhancement. Under the value-up plan, target shareholder return ratio is set at 20-50%; actual ratio reached 57% in 2025, exceeding the target.
  • The board consists of 3 inside directors and 3 outside directors, including one female director, ensuring gender diversity. The Audit Committee and Outside Director Nomination Committee are both composed entirely of outside directors, strengthening independence. However, the CEO also serves as board chair, violating the principle of separation, and no executive officer system is adopted, leaving room for improvement.
  • Internal control and risk management: No documented enterprise-wide risk management policy, and compliance officer appointment not completed. Internal accounting management system is in operation, but the audit committee support organization is not independent from management; improvement plans were disclosed. External auditor (Samil PwC) maintains audit transparency through quarterly meetings.
  • [AI Comprehensive Analysis]This report is a routine governance disclosure and does not constitute an immediate stock price catalyst. The dividend increase and share cancellation plan are positive, but persistent non-compliances such as no electronic voting, lack of succession policy, and internal control weaknesses may pose long-term governance risks. Investors should monitor the company's commitment and pace of governance improvement.

KOSPI Filing Information


  • Filing: Corporate Governance Report Disclosure
  • Company: Hansol Chemical (014680)
  • Submission: Hansol Chemical Co., Ltd
  • Receipt: 05-29-2026
  • Under KRX KOSPI Market Division